Search results
Results from the WOW.Com Content Network
Buprenorphine (like methadone) is a treatment option during pregnancy. At lower doses, buprenorphine results in the usual opioid effects; high doses beyond a certain level do not result in greater effects. [8] This is believed to result in a lower risk of overdose than some other opioids. [8]
Treatments for drug addiction during pregnancy are safe for both the mother and the baby, doctors say. Methadone and buprenorphine, ... such as methadone or suboxone, can show up temporarily in ...
Opioids can cross both the placental and blood-brain barriers, which poses risks to fetuses and newborns exposed to these drugs before birth. This exposure to opioids during pregnancy can lead to potential obstetric complications, including spontaneous abortion, abruption of the placenta, pre-eclampsia, prelabor rupture of membranes, and fetal death.
Whether use during pregnancy is safe is unclear, but use while breastfeeding is probably safe, since the dose the infant receives is 1–2% that of the maternal dose, on a weight basis. [23] [18] Buprenorphine was patented in 1965, and approved for medical use in the United States in 1981.
It is unclear if use is safe during pregnancy. [8] [13] Naltrexone is an opioid antagonist and works by blocking the effects of opioids, including both opioid drugs as well as opioids naturally produced in the brain. [8] Naltrexone was first made in 1965 and was approved for medical use in the United States in 1984.
Acetaminophen has long been considered safe to help reduce fever and relieve pain while pregnant. Here's what experts say about new claims.
The growing popularity of drugs like Ozempic, Mounjaro and Wegovy, designed to help people with Type 2 diabetes and obesity, has raised new questions about what those drugs could mean for ...
However, not all of them are safe to use during pregnancy. One of the components of bismuth subsalicylate is salicylate, which is a component that crosses the placenta. Due to this, there is an increased risk for intrauterine growth retardation, fetal hemorrhage, and maternal hemorrhage within organogenesis and in the second/third trimester. [ 12 ]